Markers of bone resorption and formation seem to be lower in diabetes patients.
C-terminal cross-link of collagen, insulin-like growth factor-1, and sclerostin may potentially predict fractures.
47 studies were included among these 1 meta-analysis, 29 cross-sectional studies, 13 randomized controlled trials, and 4 longitudinal studies.
Bone turnover in diabetes patients may fluctuate depending on the glucose level.
Longitudinal studies evaluating bone turnover markers and fractures in diabetes patients are needed.